Las Vegas, NV -- (SBWIRE) -- 12/17/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: YRC Worldwide, Inc. (NASDAQ:YRCW), Real Goods Solar, Inc. (NASDAQ:RSOL), Coronado Biosciences Inc (NASDAQ:CNDO), FreeSeas Inc (NASDAQ:FREE)
YRC Worldwide, Inc. (NASDAQ:YRCW) managed to keep its gain at 4.48% on above-normal volume of 3.84M shares. The stock settled at $13.05 after floating in a range of $12.80 to $14.39. Its latest price has reached market capitalization of $136.53 million. Its 52-week range has been $5.75 to $35.99. YRC Worldwide Inc., through its subsidiaries, provides various transportation services primarily in North America. Its YRC Freight segment offers various services for the transportation of industrial, commercial, and retail goods, such as apparel, appliances, automotive parts, chemicals, food, furniture, glass, machinery, metal, metal products, non-bulk petroleum products, rubber, textiles, wood, and other manufactured products or components. It serves manufacturing, wholesale, retail, and government customers.
For How Long YRCW will fight for Profitability? Read This Trend Analysis report
Real Goods Solar, Inc. (NASDAQ:RSOL) traded down on a volume of 3.65 million, higher than its standard daily volume. Shares have dropped-3.12% to $2.17. Over the last twelve months, the stock has gained 41.11% and faced a worst price of $0.50. Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It provides commercial and residential solar energy solutions.
Has RSOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Coronado Biosciences Inc (NASDAQ:CNDO) settled 0.93% higher at $2.17 on above-normal volume of 3.30M shares during the last trading day. The stock has its 12-month high at $12.70 and 52-week low price was $1.25. It traded in a range of $1.96 to $2.21 during the last trading day. Coronado Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include TSO or CNDO-201, which is a biologic comprising Trichuris suis ovathe, the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn?s disease, ulcerative colitis, multiple sclerosis, autism.
Why Should Investors Buy CNDO After the Recent Fall? Just Go Here and Find Out
In the last trading session, FreeSeas Inc (NASDAQ:FREE) was down on high volume, trading at a volume of 3.28M versus its average daily volume of 1.42 million shares. At $1.20, the stock has attained market capitalization of 157,816.00. FreeSeas Inc., through its subsidiaries, provides drybulk shipping services. Its vessels carry various drybulk commodities, including iron ore, grain, and coal, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice. As of December 31, 2012, the company owned and operated six Handysize dry bulk carriers and one Handymax dry bulk carrier. As of April 2, 2013, its operational fleet had approximately 197,200 dwt with the average age of 15.5 years.
Why Should Investors Buy FREE After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)